List Title | APhA DrugInfoLine

Focus on Immunizations

SORT BY: Most Recent Most Viewed

January 15, 2019

Tdap immunization during third trimester passes on protection to infants

READ

PREVIEW
Women who received the Tdap vaccine during their third trimester had neonates with higher pertussis-toxin antibody concentrations than women who were not immunized, according to results of a new...
November 13, 2018

Adolescent vaccinations not associated with fertility problems

READ

PREVIEW
Adolescent vaccinations with HPV, Tdap, inactivated influenza, and meningococcal conjugate (MenACWY) were not associated with an increased risk of primary ovarian insufficiency, according to...
August 28, 2018

Reduced influenza vaccine effectiveness observed in a select birth cohort

READ

PREVIEW
An analysis published in the Journal of Infectious Diseases of vaccine effectiveness (VE) over five influenza seasons (2010–16) showed reduced effectiveness during the 2015–16 influenza...
August 6, 2018

DTaP vaccines are safe, but take care to prevent vaccination-related errors

READ

PREVIEW
An in-depth review of data from the Vaccine Adverse Event Reporting System (VAERS) on DTaP-based vaccines over a 19-year period showed no new or unexpected safety signals, with the most common...
July 9, 2018

Communication strategies to improve HPV vaccination rates

READ

PREVIEW
Providers with a persistent communication style that focuses on the benefits of HPV vaccine and a strong recommendation to accept vaccination resulted in much higher same-day vaccination rates...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.